The cell viability analysis was performed by MTT assay as described previously.25 Briefly, Ec109, KYSE70, and Het-1A cells were seeded in a 96-well plate at a density of 8,000 cells each well and cultured overnight for attachment. The next day, the cells were treated with varying concentrations of CDDO-Me (0–5 μM) for 24 and 48 hours. Following drug treatment, the cells were incubated with 5 mg/mL MTT (10 μL/well) for 4 hours at 37°C. The reaction was terminated by the addition of 100 μL DMSO. The absorbance was measured using a Synergy™ H4 Hybrid microplate reader (BioTek Inc., Winooski, VT, USA) at a wavelength of 450 nm. The absorbance values were normalized by assigning the value of the control line in the medium without drug to 1.0 and the value of the no-cell control to 0. The half inhibitory concentration (IC50) was defined as the CDDO-Me concentration required for decreasing the cells to 50% of the control value. Experiments were performed in at least triplicate.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.